Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Sermorelin

GHRH (1-29), GRF 1-29 NH2, Sermorelin acetate

Quick Stats
Studies 223
Trials 41
Score 2
1990 pubmed

The plasma pattern of growth hormone in conscious rats during late pregnancy.

Carlsson. L L; Edén. S S; Jansson. J O JO

Key Findings

  • Mean plasma GH is roughly double in late‑pregnant rats compared to non‑pregnant controls, and spikes to four times higher on day 20.
  • The increase is driven by higher basal GH and larger pulse amplitude, not by more frequent pulses.
  • Infusing a human GRF analogue raises GH levels, but removing the pituitary (hypophysectomy) eliminates GH, confirming pituitary origin.

Practical Outcomes

  • For biohackers, this study reinforces that GH release can be amplified by GRF‑type peptides, but the effect size and timing are highly context‑dependent (e.g., pregnancy in rats). It suggests that simply adding a GRF analogue may not guarantee consistent GH spikes unless the underlying endocrine environment supports it. The findings are mostly mechanistic and not directly translatable into a ready‑to‑use sermorelin protocol for humans.

Summary

In pregnant rats, blood levels of growth hormone (GH) rise a lot during the later stages of pregnancy, especially on day 20, mainly because the baseline GH goes up and the bursts of GH become larger. Giving a human GH‑releasing factor (GRF) analogue still boosts GH, but if the pituitary gland is removed, GH disappears, showing the pituitary is the source.

Abstract

The plasma GH levels of female rats during late pregnancy were determined using an automatic method for repetitive blood sampling from conscious animals. The plasma GH patterns were analysed by a pulse analysis computer program (PULSAR). The mean plasma GH levels were about twofold higher in pregnant females on days 15, 18 and 22 of gestation than in age-matched non-pregnant females. The basal plasma GH levels were also increased, while there was no change in GH pulse amplitude or frequency. The augmentation of GH release was even more pronounced on day 20 of gestation, with a fourfold increase in mean plasma GH levels compared with those in non-pregnant females. This increase reflected an increase in both basal plasma GH levels and GH pulse amplitude, but there was no increase in pulse frequency. In female rats that delivered on day 22 of gestation, the basal and mean plasma GH levels increased during parturition. Pregnant females consistently responded to multiple i.v. infusions of 1 microgram human GH-releasing factor analogue (hGRF(1-29)-NH2) given at 45-min intervals on day 18 of gestation. Both basal and GRF analogue-stimulated plasma GH levels were undetectable after hypophysectomy of pregnant rats. The present study demonstrates an increase in basal plasma GH levels during late pregnancy and a marked increase in both basal plasma GH levels and GH pulse amplitude on day 20 of gestation. Furthermore, hypophysectomy of pregnant rats results in undetectable GH levels, indicating that the high levels of GH during pregnancy are derived from the pituitary.

Study Information

Provider

pubmed

Year

1990

DOI

10.1677/joe.0.1240191